Progress in temporal bone histopathology. II. Immuno-technology applied to the temporal bone.

Area of Science:

• Immunology
• Otolaryngology
• Pharmacology

Background:

• Aural cholesteatoma is a destructive skin growth in the middle ear.
• The cellular composition of cholesteatoma and its interaction with the tympanic membrane are not fully understood.
• Inner ear drug delivery and detection methods require advanced techniques.

Purpose of the Study:

• To determine the cellular makeup of aural cholesteatoma using immunohistochemistry.
• To investigate the presence of specific immune cells in cholesteatoma matrix compared to normal tympanic membranes.
• To demonstrate the utility of immuno-technology for tracing drugs within the inner ear, using gentamicin as a model.

Main Methods:

• Monoclonal antibodies targeting cell-membrane receptors were used to identify cells in cholesteatoma.
• Immunohistochemical staining was performed on cholesteatoma matrix and normal human tympanic membrane samples.
• A polyvalent anti-gentamicin antiserum was employed to trace gentamicin distribution in the cochlea of an animal model.

Main Results:

• Langerhans' cells and T-lymphocytes were found to be predominant in the cholesteatoma matrix.
• These immune cells were absent in the normal human tympanic membrane.
• Gentamicin was successfully detected in the cochlea of the animal model, accumulating in outer hair cells after daily injections.

Conclusions:

• Immunohistochemistry is effective in characterizing the cellular composition of aural cholesteatoma.
• The presence of immune cells in cholesteatoma suggests an inflammatory or immune-mediated component.
• Immuno-technology provides a viable method for tracking drug distribution within the inner ear structures.